Article Menu

Export Article

More by Authors Links

Article Data

  • Views 273
  • Dowloads 135

Case Reports

Open Access

Survival and reproductive function after treatment of immature ovarian teratoma

  • A. Kemal Uzunlar1,*,
  • A. Yalinkaya2
  • M. Yaldiz1
  • N. Kilinc1
  • T. Gul2

1Department of Pathology, The Medical Faculty of Dicle University, Diyarbakir, Turkey

2Department of Obstetrics and Gynecology, The Medical Faculty of Dicle University, Diyarbakir, Turkey

DOI: 10.12892/ejgo200105384 Vol.22,Issue 5,September 2001 pp.384-386

Published: 10 September 2001

*Corresponding Author(s): A. Kemal Uzunlar E-mail:

PDF (368.49 kB)

Abstract

We conducted a clinical and pathologic review of nine patients with immature ovarian teratoma. The histologic grade of the tumor seemed to be a reliable indicator of prognosis. Low stage and low grade immature ovarian teratomas have an excellent prognosis. Platinum-based chemotherapy has been confirmed to be effective in the management of patients with ovarian germ cell tumors. Low grade pure ovarian immature teratoma is a potentially curable disease and a fertility-sparing surgical approach is possible.

Keywords

Reproductive function; Immature ovarian teratoma.

Cite and Share

A. Kemal Uzunlar,A. Yalinkaya,M. Yaldiz,N. Kilinc,T. Gul. Survival and reproductive function after treatment of immature ovarian teratoma. European Journal of Gynaecological Oncology. 2001. 22(5);384-386.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200105384

References

[1] Kawai M., Kano K., F uruhashi Y.. Iwata M.. Nakashima I. N.. Kuzuya K., et al.: "Immature teratoma of the ovary". Ohstet. Gynecol., 1991, 40, 133.

[2] Berek S. J., Adashi E. Y., Hillard P. A.: "Novak 's Gynecology". 12th edition. Ovarian Cancer, Baltimore, 1996, 1155.

[3] Nielsen S. N., Gaffey T. A., Malkasian G.D.: "Immature ovanan teratoma. A review of 14 cases". Mayo Clin. Proc., 1986, 61, 110.

[4] Thurlbeck W. N., Scully R. E.: "Solid teratoma of the ovary: a clinicopathological analysis of 9 cases". Cancer, 1960, 13, 804.

[5] Norris H. J., Zirkin H.J., Benson W. L.: "Immature (malignant) teratoma of the ovary: a clinical and pathological study of 58 cases". Cance,; 1976, 37, 2359.

[6] Kojs Z., Urbanski K., Mitus J., Reinfuss M., Pudelek J., Walasek T.: "Pure immature teratoma of the ovary: analysis of 22 cases". Eu,: J. Gynaecol. Oncol., 1997, 18, 534.

[7] Gallion H., van Nagell J. R.,D onaldson E. S., Hanson M. B., Powell D. F.: "Immature teratoma of the ovary". Am. J. Obstet. Gynecol., 1983, 146, 361.

[8] Nogales F. F., F avara B. E., Major F. J., Silverberg S. G.: "Immature teratoma of the ovary with a neural component ("solid" teratoma) a clinicopathologic study of 20 cases". Hum. Pathol., 1976, 7, 625.

[9] Truong L. D.,J urco S. III, Gavran M. H.: "Gliomatosis peritonei report of two cases and review of literature". Am. J. Surg. Pathol.. 1982, 6, 443.

[10] Tewari K., Cappuccini F.,D 心ia P. J.,B erman M. L.,M anetta A., Kohler M. F.: "Malignant germ cell tumors of the ovary". Obstet Gynecol., 2000, 95, 128.

[11] Gershenson D. M.,D eljunco G., Silva E. G., Copeland L. J., W harton J. T.: "Immature teratoma of the ovary". Obstet. Gynecol., 1986, 68, 624.

[12] Slayton R. E., Park R. C., Silverberg S. G., Shingleton H., Creasman W. T., Blessing J. A.: "Vincristine, dactinomycn, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary". Cancer, 1985, 56, 243.

[13] Mitchell P. L., Al-Nasiri N., A'Hern R., F isher C., Horwich A., Pinkerton C. R., et al.: "Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases". Cancer, 1999, 85, 2232.

[14] Zanetta G., Bonazzi C., Cantu M., Binidagger S., Locatelli A., Bratina G., Mangioni C.: "Survival and reproductive function after treatment of malignant germ cell ovarian tumors". J. Clin. Oncol., 2001, 19, 1015.

[15] Gershenson D. M.: "Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors". J. Clin. Oncol., 1988, 6, 270.

[16] Ezzat A., Raja M., Bakri Y., Subhi J., Memon M., Schwartz P., Stuart R.: "Malignant ovarian germ cell tumours - a survival and prognostic analysis". Acta Oneal., 1999, 38, 455.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top